BR112015007674A2 - processo aperfeiçoado para purificar lactoferrina de leite e produtos do mesmo - Google Patents
processo aperfeiçoado para purificar lactoferrina de leite e produtos do mesmoInfo
- Publication number
- BR112015007674A2 BR112015007674A2 BR112015007674A BR112015007674A BR112015007674A2 BR 112015007674 A2 BR112015007674 A2 BR 112015007674A2 BR 112015007674 A BR112015007674 A BR 112015007674A BR 112015007674 A BR112015007674 A BR 112015007674A BR 112015007674 A2 BR112015007674 A2 BR 112015007674A2
- Authority
- BR
- Brazil
- Prior art keywords
- milk
- lactoferrin
- purifying
- improved process
- products
- Prior art date
Links
- 102000010445 Lactoferrin Human genes 0.000 title abstract 5
- 108010063045 Lactoferrin Proteins 0.000 title abstract 5
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title abstract 5
- 229940078795 lactoferrin Drugs 0.000 title abstract 5
- 235000021242 lactoferrin Nutrition 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 235000013336 milk Nutrition 0.000 title abstract 4
- 239000008267 milk Substances 0.000 title abstract 4
- 210000004080 milk Anatomy 0.000 title abstract 4
- 238000001914 filtration Methods 0.000 abstract 2
- 239000012466 permeate Substances 0.000 abstract 2
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000012465 retentate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Analytical Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Obesity (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012904391A AU2012904391A0 (en) | 2012-10-08 | Improved process for purifying milk proteins and products thereof | |
| AU2013204858A AU2013204858B2 (en) | 2012-10-08 | 2013-04-12 | Improved process for purifying milk proteins and products thereof |
| PCT/AU2013/001152 WO2014056025A1 (en) | 2012-10-08 | 2013-10-08 | Improved process for purifying lactoferrin from milk and products thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015007674A2 true BR112015007674A2 (pt) | 2017-07-04 |
Family
ID=50476773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015007674A BR112015007674A2 (pt) | 2012-10-08 | 2013-10-08 | processo aperfeiçoado para purificar lactoferrina de leite e produtos do mesmo |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10016487B2 (enExample) |
| EP (1) | EP2904006A4 (enExample) |
| JP (1) | JP6475163B2 (enExample) |
| KR (1) | KR20150068404A (enExample) |
| CN (1) | CN104768971B (enExample) |
| AU (1) | AU2013204858B2 (enExample) |
| BR (1) | BR112015007674A2 (enExample) |
| CA (1) | CA2886892A1 (enExample) |
| IN (1) | IN2015DN02971A (enExample) |
| NZ (1) | NZ631826A (enExample) |
| RU (1) | RU2683228C2 (enExample) |
| WO (1) | WO2014056025A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013204858B2 (en) | 2012-10-08 | 2015-06-25 | Saputo Dairy Australia Pty Limited | Improved process for purifying milk proteins and products thereof |
| CN106215174A (zh) * | 2016-08-04 | 2016-12-14 | 无锡科捷诺生物科技有限责任公司 | 一种人乳铁蛋白的制剂化制备方法 |
| EP3809880A4 (en) | 2018-06-22 | 2022-03-23 | Fonterra Co-Operative Group Limited | USE OF POLAR LIPIDS TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS |
| JP7370224B2 (ja) * | 2019-11-08 | 2023-10-27 | ライオン株式会社 | ラクトフェリン含有腸溶製剤 |
| FR3115037B1 (fr) * | 2020-10-12 | 2025-02-21 | Cie Laitiere Europeenne | Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue |
| CN113278063A (zh) * | 2021-05-13 | 2021-08-20 | 上海仁统生物科技中心 | 一种利用超滤法自初乳中获取乳铁蛋白的方法 |
| IL311036A (en) * | 2021-08-23 | 2024-04-01 | Lactea Therapeutics Llc | Lactoferrin compositions and methods of use |
| PL444766A1 (pl) * | 2023-05-07 | 2024-11-12 | Polmlek Spółka Z Ograniczoną Odpowiedzialnością | Sposób uzyskiwania laktoferyny w proszku z surowego mleka |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2584727B1 (fr) * | 1985-07-11 | 1988-06-17 | Roussel Uclaf | Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques |
| US5221734A (en) | 1987-10-01 | 1993-06-22 | Ciba-Geigy Corporation | Process for preparing a polypeptide growth factor for milk |
| GB8729031D0 (en) * | 1987-12-11 | 1988-01-27 | Express Foods Group Ltd | Isolation of immunoglobulin rich fraction from whey |
| JP2686831B2 (ja) * | 1989-09-22 | 1997-12-08 | 雪印乳業株式会社 | 鉄結合性蛋白質を分離、精製し、採取する方法 |
| ATE129125T1 (de) * | 1992-01-15 | 1995-11-15 | Campina Melkunie Bv | Verfahren zur isolierung von lactoferrin und lactoperoxidase aus milch und milchprodukten. |
| JPH05202098A (ja) | 1992-01-29 | 1993-08-10 | Snow Brand Milk Prod Co Ltd | 乳質原料から生理活性物質の製造法 |
| US5756680A (en) * | 1994-01-05 | 1998-05-26 | Sepragen Corporation | Sequential separation of whey proteins and formulations thereof |
| WO1995022258A2 (en) * | 1994-02-16 | 1995-08-24 | Pharming Bv | Isolation of lactoferrin from milk |
| NL1005677C2 (nl) * | 1997-03-27 | 1998-09-29 | Campina Melkunie Bv | Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan. |
| CN1555384B (zh) * | 2001-07-20 | 2010-05-26 | 坎皮纳公司 | 从乳制品获得具有低相互交叉污染的生长因子(TGF-β和IGF-1)、乳过氧化物酶和免疫球蛋白制剂的方法 |
| US6875459B2 (en) * | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
| DK1480524T3 (da) * | 2002-03-07 | 2013-07-15 | Upfront Chromatography As | Fremgangsmåde til isolering af lactoferrin |
| FR2841747B1 (fr) * | 2002-07-02 | 2004-08-20 | Cie Laitiere Europeenne | Isolat de proteines de lait et procede pour sa preparation |
| GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
| US20050208638A1 (en) * | 2004-03-22 | 2005-09-22 | Chao Wu | Process for preparing bioactive protein-enriched whey products |
| US8252341B2 (en) | 2004-09-14 | 2012-08-28 | Paul Brazeau | Isolation of growth and differentiating factors from colostrum |
| KR101540412B1 (ko) * | 2005-09-09 | 2015-07-29 | 머레이 걸번 코-어퍼러티브 컴퍼니 리미티드 | 근육 염증 감소용 유장 성장 인자 추출물의 조성물 |
| FR2901796A1 (fr) | 2006-05-31 | 2007-12-07 | Lab Francais Du Fractionnement | Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait |
| WO2008055310A1 (en) * | 2006-11-10 | 2008-05-15 | Murray Goulburn Co-Operative Co. Limited | Process for the preparation of angiogenin |
| JP5717625B2 (ja) * | 2008-05-14 | 2015-05-13 | アグリカルチャー ヴィクトリア サービス ピーティーワイ エルティーディーＡｇｒｉｃｕｌｔｕｒｅ Ｖｉｃｔｏｒｉａ Ｓｅｒｖｉｃｅｓ Ｐｔｙ Ｌｔｄ | アンギオゲニン濃縮ミルク分画 |
| AU2010231075B2 (en) | 2009-01-28 | 2015-06-11 | Jean-Paul Perraudin | Method for production of lactoferrin |
| CN102413868B (zh) * | 2009-04-23 | 2013-08-21 | 株式会社Jms | 医疗用连接器 |
| WO2012015037A1 (ja) | 2010-07-30 | 2012-02-02 | 森永乳業株式会社 | 抗菌活性増強剤 |
| AU2013204858B2 (en) * | 2012-10-08 | 2015-06-25 | Saputo Dairy Australia Pty Limited | Improved process for purifying milk proteins and products thereof |
-
2013
- 2013-04-12 AU AU2013204858A patent/AU2013204858B2/en active Active
- 2013-10-08 KR KR1020157010356A patent/KR20150068404A/ko not_active Abandoned
- 2013-10-08 EP EP13844731.3A patent/EP2904006A4/en not_active Withdrawn
- 2013-10-08 RU RU2015116933A patent/RU2683228C2/ru not_active IP Right Cessation
- 2013-10-08 JP JP2015534883A patent/JP6475163B2/ja not_active Expired - Fee Related
- 2013-10-08 NZ NZ631826A patent/NZ631826A/en not_active IP Right Cessation
- 2013-10-08 CN CN201380055328.7A patent/CN104768971B/zh not_active Expired - Fee Related
- 2013-10-08 CA CA2886892A patent/CA2886892A1/en not_active Abandoned
- 2013-10-08 US US14/434,324 patent/US10016487B2/en active Active
- 2013-10-08 BR BR112015007674A patent/BR112015007674A2/pt not_active Application Discontinuation
- 2013-10-08 WO PCT/AU2013/001152 patent/WO2014056025A1/en not_active Ceased
-
2015
- 2015-04-09 IN IN2971DEN2015 patent/IN2015DN02971A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2015DN02971A (enExample) | 2015-09-18 |
| CN104768971B (zh) | 2017-12-05 |
| AU2013204858B2 (en) | 2015-06-25 |
| US20150315264A1 (en) | 2015-11-05 |
| JP2015536905A (ja) | 2015-12-24 |
| WO2014056025A8 (en) | 2015-05-14 |
| CA2886892A1 (en) | 2014-04-17 |
| AU2013204858A1 (en) | 2014-04-24 |
| EP2904006A4 (en) | 2016-04-06 |
| JP6475163B2 (ja) | 2019-02-27 |
| CN104768971A (zh) | 2015-07-08 |
| RU2683228C2 (ru) | 2019-03-26 |
| EP2904006A1 (en) | 2015-08-12 |
| KR20150068404A (ko) | 2015-06-19 |
| US10016487B2 (en) | 2018-07-10 |
| RU2015116933A (ru) | 2016-11-27 |
| NZ631826A (en) | 2017-08-25 |
| WO2014056025A1 (en) | 2014-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015007674A2 (pt) | processo aperfeiçoado para purificar lactoferrina de leite e produtos do mesmo | |
| MX2019000881A (es) | Producto lacteo y proceso. | |
| MX2016012716A (es) | Compuestos y metodos para suministro trans-membrana de moleculas. | |
| ZA201904407B (en) | System and method for the treatment of water by reverse osmosis or nanofiltration | |
| WO2014117000A3 (en) | Water treatment systems for fluid preparation | |
| BR112016024632A2 (pt) | métodos de purificação de rna mensageiro | |
| EP4039812C0 (en) | REGENERATION OF FUNCTIONAL NEURONS FOR THE TREATMENT OF NEURAL INJURY CAUSED BY BLOOD FLOW DISTURBANCE | |
| EP3458635C0 (en) | ONLINE WIRE PROCESSING SYSTEM | |
| EP2416655A4 (en) | METHODS FOR PREVENTING AND / OR TREATING DEGENERATIVE DISORDERS IN THE CENTRAL NERVOUS SYSTEM | |
| WO2013150126A3 (de) | Verfahren zur behandlung von blut, blutprodukten und organen | |
| SG10202006102UA (en) | Processes For Filtering Liquids Using Single Pass Tangential Flow Filtration Systems AndTangential Flow Filtration Systems With Recirculation of Retentate | |
| BR112016014855A2 (pt) | Sal de laticínio, método para sua produção e produtos alimentícios contendo o mesmo | |
| IN2014DN10979A (enExample) | ||
| CL2015002704A1 (es) | Proceso para el tratamiento del agua antes de la osmosis inversa. | |
| EP3522169A4 (en) | AUXILIARY SYSTEM FOR BLOOD PURIFICATION TREATMENT | |
| EP2663193A4 (en) | CARBON MONOXIDE SOLUTION FOR TREATMENT OF DISEASE, IN PARTICULAR DREPANOCYTOSIS | |
| BR112016009715B8 (pt) | Sistema de tratamento de fluido | |
| EP3352684C0 (fr) | Système pour le traitement d'une épistaxis | |
| EA201691563A1 (ru) | Сухой кислотный концентрат в гранулированной форме | |
| EP3462906A4 (en) | METHOD AND ADDITION TO THE PREVENTION AND TREATMENT OF GASTROINTESTINAL LEAD IN HORSES AND OTHER SPECIES | |
| BR112017001039A2 (pt) | método para extrair proteínas solúveis de biomassa de microalgas | |
| BR112015007675A2 (pt) | melhoria do processo de fatores de crescimento purifying a partir de leite e produtos derivados | |
| EP3522827A4 (en) | DEVICES AND METHODS FOR TREATING CONGESTIVE HEART FAILURE, ASCITES, AND OTHER DISORDERS RELATED TO EXCESS BODY FLUID | |
| BR112015001973B8 (pt) | método para produzir um líquido de açúcar | |
| EA201600628A1 (ru) | Способ регенерации кислоты или основания |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B25A | Requested transfer of rights approved |
Owner name: SAPUTO DAIRY AUSTRALIA PTY LIMITED (CA) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |